Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease.
about
Emerging preclinical pharmacological targets for Parkinson's diseaseNeurodegeneration and microtubule dynamics: death by a thousand cutsMeiotic chromosome mobility in fission yeast is resistant to environmental stress.Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset EncephalopathySirtuin-2 Protects Neural Cells from Oxidative Stress and Is Elevated in Neurodegeneration.Back to the tubule: microtubule dynamics in Parkinson's disease.Pyridine Dinucleotides from Molecules to Man.Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells.Epigenetic regulation in Parkinson's disease.Sirtuins as modifiers of Parkinson's disease pathology.Mitochondrial Metabolism Regulates Microtubule Acetylome and Autophagy Trough Sirtuin-2: Impact for Parkinson's Disease.Microtubule Destabilization Paves the Way to Parkinson's Disease.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy ResistanceOverexpression of Sirtuin2 prevents high glucose-induced vascular endothelial cell injury by regulating the p53 and NF-κB signaling pathways.Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.SIRT2 mediates NADH-induced increases in Nrf2, GCL, and glutathione by modulating Akt phosphorylation in PC12 cells.Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone.Frataxin silencing alters microtubule stability in motor neurons: implications for Friedreich's ataxia.
P2860
Q26764724-14D7D77D-A381-4392-BC42-C2C944E364FCQ26781649-A2141DA2-0352-4550-B4F3-81E3F42054CCQ27322714-CC50FF74-2853-47A6-A246-F26130E878ACQ28975762-9316B1C5-5CA5-47EF-9F84-65B72581DFB7Q33786835-BD571E2E-7C8B-4F22-8E15-9317DA98C2E6Q37590635-2B2382F7-7511-48D8-AA87-B189031CD996Q38668667-24DAA36C-79A1-42F3-93FA-F5AF7DA7B4F7Q38763646-2549AC8D-1F4B-42A1-AB7B-788C52387AC1Q38881221-66E9B1E7-DF6E-47CE-BBD1-63262895BF9CQ38893382-1DF4AB79-4B75-40EF-8F06-5457F01B16A5Q38974971-55E9A431-75C4-42C0-8586-0CC0CA252E7EQ38984991-D3910D3F-BC7D-4352-9849-9E971C5279C3Q39414846-A068CC91-50E2-42EB-B547-B6D2C77B49A4Q46251211-D2DC1D51-F8B9-48CC-A758-2EDAAF7B2C4CQ47611066-F0ABB1E1-3F32-49A5-8110-EB0B57C288F5Q47870236-CBAE216A-4395-45F5-AE1D-EF00B5637655Q48423771-D0C0E5FD-EA48-45E0-A534-A683E6427ABFQ51575796-17C1E316-6099-499F-8014-409FDE9E7E82
P2860
Decreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@ast
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@en
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@nl
type
label
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@ast
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@en
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@nl
prefLabel
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@ast
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@en
Decreased SIRT2 activity leads ...... tions for Parkinson's disease.
@nl
P2860
P1476
Decreased SIRT2 activity leads ...... ations for Parkinson's disease
@en
P2093
Vivek P Patel
P2860
P304
P356
10.1016/J.EXPNEUROL.2014.04.024
P407
P577
2014-05-02T00:00:00Z